Cardiometabolic Beat Podcast

Dr. Filomena Trindade, a physician, teacher, author, and internationally recognized speaker who focuses on functional medicine and a holistic preventative approach to care discusses the potential reversal of Type 2 Diabetes. You don't want to miss what she has to say! Also, don't forget to rate, subscribe or follow, and leave a 5 star review!

Tune in to listen to Kenneth Cusi, MD talk about the increasing burden of NAFLD and NASH, important considerations for screening and diagnosis that clinicians in the community should be aware of, as well as perspectives about current and emerging treatments.

Listen in as Dr. George Bakris, the Director of the Comprehensive Hypertension Center and kidney disease specialist, discusses the latest cardiometabolic concepts and new ways to help create helpful healing plans for patients.

Listen in as Dr. Mark Houston, the Director of the Hypertension Institute - tripled boarded in hypertension as an American Society of Hypertension specialist, a Fellow of the American Society of Hypertension, Internal Medicine, and Anti-aging medicine discusses the emerging strategies in cardiometabolic medicine.

Despite therapeutic advances, the cardiometabolic disease burden remains disproportionally high in patients from racial and ethnic populations. The reasons for these disparities are complex and underlined by social determinants of health and limited access to appropriate healthcare, among other factors. During this webinar, Dr. Keith C. Ferdinand, MD, hosted a panel with key opinion leaders to dis...

Listen in as Fatima Stanford, MD, Associate Professor of Medicine and Pediatrics, as well as Equity Director at Massachusetts General Hospital Endocrine Division, shares some practical pearls about addressing disparities in the management of obesity.

Tune in to hear Javed Butler, MD, renowned heart failure (HF) specialist and the principal investigator of several major HF trials, discuss the evolving paradigms of HF care, including the role of SGLT-2 inhibitors as part of foundational therapy, as well as other newer and emerging treatment options and their role in the treatment landscape.

Listen in to our conversation with renowned nephrologist and long-term CMHC faculty Mathew R. Weir, MD, who is Professor of Medicine and Division Head of Nephrology at University of Maryland School of Medicine. In this podcast, Dr. Weir covers the exciting new developments in the management of CKD, including SGLT-2 inhibitors and beyond, as well as practical pearls for better adopting these advanc...

Listen in to our conversation with Linda Shiue, MD, an internist and professionally trained chef in the department of Adult and Family Medicine and the Director of Culinary Medicine at Kaiser Permanente San Francisco, and the author of the cookbook "Spicebox Kitchen: Eat Well and Be Healthy with globally inspired, vegetable-forward recipes".  In the podcast, she shares her unique insights on food...

VTE: A Discussion on Screening, Prevention, and Transition of Care   Listen in as Dr. Geoffrey Barnes, Assistant Professor of Medicine, as well as a cardiologist and vascular medicine specialist at the University of Michigan Health system, shares his clinical perspectives on the prevention and management of venous thromboembolism (VTE).   Recorded September 16, 2021.

COVID-19 and New-Onset Diabetes   Listen in as Dr. Irl Hirsch, Professor of Medicine and Diabetes Treatment and Teaching Chair at the University of Washington Medical Center in Seattle, WA., presents on an intriguing topic, that of new-onset diabetes due to COVID-19.   Recorded September 21, 2021.

Listen in as Dr. Vanita Aroda, Director of Diabetes Clinical Research at the Brigham and Women's Hospital in Boston and faculty at Harvard Medical School, covers the ever-changing landscape and paradigm shifts in the management of patients with type 2 diabetes. Recorded September 14, 2021

Listen in as Dr. Keith Ferdinand, Professor of Medicine and Gerald S. Berenson Endowed Chair in Preventive Cardiology at the Tulane University School of Medicine and the Tulane Heart and Vascular Institute in New Orleans, Louisiana shares his insight on ethnic & racial disparities in cardiometabolic health. Dr. Ferdinand has dedicated his career to improving these disparities, and was more recentl...

Listen in as Dr. Adam DeVore, cardiologist and Associate Professor of Medicine at Duke University School of Medicine in Durham, North Carolina share results from the CONNECT-HF trial.   Recorded Date July 12, 2021

Dr. Hallberg is a nationally and internationally recognized expert in the field of carbohydrate restriction for type 2 diabetes, and part of the largest and longest trial to date in this field. In this interview Dr. Hallberg discusses the evidence behind ketogenic/low carb diets in reducing cardiometabolic risk and much more.

Listen to CMHC's Senior Planning Committee Member and Spring 2021 Keynote, Dr. Keith C. Ferdinand, Professor of Medicine at the Tulane University School of Medicine in New Orleans, LA, discuss ethnic and racial disparaties among caring for patients with cardiometabolic risk and COVID-19.

Dr. Harold Bays, Medical Director and President of the Louisville Metabolic and Atherosclerosis Research Center as well as Your Body Goal in Louisville, KY., and Chief Science Officer of Obesity Medicine Association shares his insight on obesity pharmacotherapy, cardiometabolic consequences of obesity as well as how the COVID-19 pandemic impacts obesity management.

Since the month of May is celebrated as Asian Pacific Heritage Month, in this podcast, we had an opportunity to talk with Dr. Leslie Cho, Professor of Medicine and Head of Preventive Cardiology and Rehabilitation at the Cleveland Clinic, Ohio, about the prevalence and management of statin intolerance particularly in individuals of East Asian descent.

In this podcast, CMHC Chair Robert Eckel, MD, co-president of the American Diabetes Association and Professor of Medicine at University of Colorado in Aurora, discusses the connections between obesity and COVID-19, as well as some updates on diabetes therapy in patients with diabetes and COVID-19.   Recorded April 27, 2020.

In this podcast, CMHC Chair Christie Ballantyne, MD, Professor of Medicine at Baylor College of Medicine, discusses the role of troponins and statins in COVID-19, and how has the pandemic impacted his practice.

In this podcast, Dr. Clyde Yancy, Professor of Medicine at Northwestern, discusses the connections between CVD and COVID-19, including cardiac injury, RAASi therapy, and more.